Sign In
Buy LUDG
$0.0302
+0 (+0%)
At Close: Jun 03, 2026
Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
09:00am, Thursday, 29'th May 2025
MIAMI, FL / ACCESS Newswire / May 29, 2025 / Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
09:30am, Wednesday, 07'th May 2025
Ludwig Enterprises, Inc. (OTC:LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis. MIAMI, FL / ACCESS Newswire / May 7, 2025 / Ludwig Ente
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
09:00am, Tuesday, 29'th Apr 2025
Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
09:00am, Wednesday, 23'rd Apr 2025
Charles T. Todd, Jr. named CEO and Chair of the Board MIAMI, FLORIDA / ACCESS Newswire / April 23, 2025 / Ludwig Enterprises, Inc. (the "Company"), has appointed Charles T. Todd, Jr. as Chief Executiv
Ludwig Enterprises Begins PCR Validation Test Process
09:00am, Thursday, 07'th Nov 2024
Final step before the full launch of breast cancer screening program, Revealia™ SPARKS, NV / ACCESSWIRE / November 7, 2024 / Ludwig Enterprises, Inc. (OTC PINK:LUDG), a leading USA-based biotechnolo
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
08:30am, Thursday, 24'th Oct 2024
SPARKS, NV / ACCESSWIRE / October 24, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has filed a provisional patent for its breakthrough cancer detection m
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
10:35am, Tuesday, 24'th Sep 2024
This press release replaces the release issued today at 9:15am EDT. Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy.
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
09:15am, Tuesday, 24'th Sep 2024
Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine
Ludwig Announces Acquisition of Intellectual Property and Patent
09:35am, Tuesday, 17'th Sep 2024
SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and pa
Nova Mentis Assigns Intellectual Property
09:00am, Tuesday, 27'th Aug 2024
Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered
Ludwig Announces Substantial Corporate Initiatives
09:01am, Wednesday, 14'th Aug 2024
Revealia™, the world's most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA-based biotechnology compan
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
08:00am, Tuesday, 09'th Jul 2024
SPARKS, NV / ACCESSWIRE / July 9, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNA
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
07:30am, Wednesday, 27'th Mar 2024
SPARKS, NV / ACCESSWIRE / March 27, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased to announce that its subsidiary Exousia AI is funding a preclinical stu
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence cancer
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
08:00am, Wednesday, 06'th Mar 2024
SPARKS, Nev., March 06, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc. (OTC: LUDG): A US-based biotechnology company is pleased to announce the successful filing of its provisional patent, title �
